Cancers Events Announce Your Event Here

No upcoming events

21–22 September 2017 Global Precision Medicine & Biomarkers Leaders Summit

Munich, Germany

The Precision Medicine and Biomarkers Leaders Summit will provide a forum to network, learn and engage with senior representatives of
leading pharmaceutical and biotech companies worldwide.

More intimate roundtable discussions will also provide an opportunity for you and your peers to cover, in detail, issues such as fulfilling the potential of big data, conducting precision medicine clinical trials and advancing liquid biopsies to the clinic.

http://www.global-engage.com/event/global-precision-biomarkers-leaders/

26–28 September 2017 6th International Conference on Biotechnology and Bioengineering

Offenburg, Germany

The 6th International Conference on Biotechnology and Bioengineering (6-ICBB 2017) will be held in Offenburg, Germany during 26–28 September, 2017.
The conference has been designed to provide an innovative and comprehensive overview of biotechnology and bioengineering, and a focus will be given to major research advances, including: New Approaches and Concepts in Biotechnology; Cell and Immunology; Genomics and Molecular Biology; Enzyme and Protein Engineering; Biomedicine, Pharmaceutical Biotechnology and Toxicology; Bioinformatics and Systems Biology; Biomedical Engineering; Biomedical Techniques and Technologies, and other related aspects. More information about the conference can be found at 

http://www.icbb.hs-offenburg.de/

5–6 October 2017 7th. InterAmerican Oncology Conference

Buenos Aires, Argentina

The 7th InterAmerican Oncology Conference "Current Status and Future of Anti-Cancer Targeted Therapies" will be held in Buenos Aires, Argentina in October 5th and 6th, 2017.

An outstanding faculty of speakers from the United States and Europe has committed in this meeting.

The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types. The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies and emerging treatments in early development.

http://www.oncologyconferences.com.ar/

9–10 October 2017 2nd Annual Biomarkers & Precision Medicine USA Congress

San Diego, USA

Oxford Global Conferences are proud to present the 2nd Annual Biomarkers & Precision Medicine USA Congress co-located with our 4th Annual Drug Discovery USA Congress, taking place on the 09-10 October 2017 in San Diego, USA.

Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions.

Over 40 presentations, case studies and panel discussions focused on the key issues in biomarker research, companion diagnostics, personalised medicine and clinical biomarkers.

5 Interactive Streams:

  • Biomarkers in Drug Discovery and Development – Translation and Precision Medicine in Auto-Immune Diseases, CNS, Oncology, and Infectious Diseases
  • Personalised Medicine, Companion Diagnostics & Patient Testing
  • Innovations in Biomarker Research – Informatics, Data Management, Assay Development, Imaging Technologies
  • Biomarker in Clinical Development & Clinical Trials
  • Clinical Diagnostics, NGS & Genomic Markers and Genetic Testing

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities. This event is co-located with our 4th Annual Drug Discovery USA Congress.

Free Pre-Congress Webinars

Translational Biomarkers and Companion Diagnostics Development Consortium
22nd June 2017, 9 am. PST, 12 noon EST, 5 pm. BST

Click here to register today, for free.

Scientific and Regulatory Considerations for the Analytical Validation of Assays for the Qualification of Biomarkers

8th August 2017, 9 am. PST, 12 noon EST, 5 pm. BST
Click here to register today, for free.

Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.

For further information, click here: http://bit.ly/22r99ki

http://www.biomarkersusa-congress.com/

10–11 October 2017 7th Annual NGS & Clinical Diagnostics Asia Congress

Concorde Hotel Singapore

Oxford Global are proud to announce the return of the NGS & Clinical Diagnostics Asia Congress. Taking place on 10-11 October 2017 at the Concorde Hotel Singapore, this event will attract 300+ delegates, representing leading sequencing centres, global pharmaceutical organisations and world-renowned research institutions.

Over 35+ presentations and case studies focused on the key developments in sequencing, analysis and bioinformatics, clinical and therapeutic applications and ‘omics case studies, will be discussed across the two days.

The two streams will focus on:

• NGS Technologies and Key Therapeutic Applications
• Clinical Applications of NGS – Based Genomic Profiling and Molecular Diagnostics

Download the full congress agenda here: https://www.ngsasia-congress.com/download-agenda-2/

Alternatively, contact Danielle Dalby: d.dalby@oxfordglobal.co.uk

https://www.ngsasia-congress.com/download-agenda-2/

23–24 October 2017 3rd Annual NGS & Clinical Diagnostics USA Congress

Boston, USA

Oxford Global are pleased to announce the 3rd Annual NGS & Clinical Diagnostics USA Congress, taking place on 23-24 October 2017 in Boston USA. Join over 180 delegates representing internationally renowned research & academic institutions, clinical and research institutions, as well as leading pharmaceutical and biotech companies. Hear over 60 presentations and case studies focused on NGS data analysis, utilising NGS in different therapeutic areas as well as NGS in precision medicine and diagnostics development.

http://www.nextgenerationsequencingusa-congress.com/

9–10 November 2017 9th Annual NGS & Clinical Diagnostics UK Congress

London, UK

Oxford Global are pleased to announce the return of Europe’s largest Genomics Congress: the 9th Annual NGS & Clinical Diagnostics Congress.

Join 600+ end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies

Hear 90+ case studies and presentations focused on the developments in NGS technologies, NGS data analysis as well as clinical applications & diagnostics of NGS.

New to 2017!

Learn more about NGS in pharma: biomarker development, precision medicine and clinical diagnostics. Case studies at this genomics conference include: linking NGS to clinical trials, biomarkers for precision therapies and innovative biology.

NGS, genomics and clinical diagnostics in healthcare: at this genomics conference, discuss the latest microbiome research results, updates in the clinical applications of NGS in healthcare and clinical metagenomics updates.

Download the full congress agenda here: https://www.nextgenerationsequencing-congress.com/download-agenda/

https://www.nextgenerationsequencing-congress.com/download-agenda/

15–16 February 2018 13th Annual Biomarkers Congress

Manchester, UK

Oxford Global is proud to present the 13th Annual Biomarkers Congress to be held on 15-16 February 2018 in Manchester.

The congress covers novel developments in biomarker discovery and validation, translation into the clinic, personalised healthcare, Big data management, clinical diagnostics development. Key therapeutic focus areas include Immuno Oncology, Neuroscience, Respiratory, Metabolic and Cardiovascular Diseases.

Attended by over 300 biomarker experts, congress will include representatives from the companies including Bayer, Roche, Merck, UCB, Pfizer. The high quality and outstanding interactive programme includes 2 pre-event webinars, 50 expert presentations, a workshop and 8 round table discussions.

Do not miss out on the latest developments in biomarker innovations, state of the art technologies, and drivers into biomarker development such as precision medicine, immuno-assays and screening processes, histology, immunohistochemistry, big data analytics, new technologies in translation and the prediction of patient population.

View the Agenda here: http://bit.ly/2v4APod

Free Pre-Congress Live Webinar

Predictive and Efficacy Biomarkers in Cancer Research
Tuesday 28th November 2018 | 10am GMT
Hosted by Mattias Bergqvist, VP Clinical Development, Biovica International and Sue Burchill, Professor of Adolescent and Paediatric Cancer Research, Leeds Institute of Cancer and Pathology.

Register today for free: http://bit.ly/2xT7TR9

Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.

For further information, prices & discounts please contact a.fernandez@oxfordglobal.co.uk

http://bit.ly/2v4APod

16–17 April 2018 5th Annual Biosimilars & Biobetters Congress

London, UK

Oxford Global Conferences are proud to present the 5th Annual Biosimilars & Biobetters Congress  co-located with the 11th Annual Proteins & Antibodies Congress and the 5th Annual Peptides Congress, taking place on the 16-17 April 2018 in London.

Over 450 proteins, peptides and biosimilars delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions

Over 20 presentations and case studies focusing on the key areas of the biosimilars industry including market access strategies, clinical development, commercialisation, manufacturing and bio-analytics

Two-day interactive conference addressing the following topics:

  • Market Access Strategies, Opportunities, Clinical Development and Commercial Challenges
  • Developing Biosimilars and Biobetters – Manufacturing and Bio-analytics 

View Agenda here: http://bit.ly/2eFkKL6

Free Pre-Congress Live Webinars

Biosimilars: Everyday Practice, Manufacturing Pre-Clinical Trials
Hosted by Katalin Egyed, International Oncology and Onco-biotechnology Business Unit Manager, EGIS Pharmaceuticals and Rafał Derlacz, Senior Project Manager, Polpharma.
Wednesday 7th February 2018 | 10am GMT

Register today for free: http://bit.ly/2xNJGbG

Biosimilars: The Cancer Patient Perspective
Hosted by Lydia Makaroff, Director, European Cancer Patient Coalition
Tuesday 13th February 2018 | 10am GMT

Register today for free: http://bit.ly/2j1vAAf

Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.

For further information, prices & discounts please contact a.fernandez@oxfordglobal.co.uk

https://www.biosimilars-congress.com/

3–5 May 2018 ISMRC2018

Corum in Montpellier, France

After great cities like Munich, Berlin, Oslo, San Francisco, Hamburg, Athens, Osaka & Paris, the next ISMRC will take place May 3-5, 2018 at the Corum in Montpellier, France.

The international ISMRC meetings started in 1996 and have established themselves, every other year, as a premier event focusing on Minimal Residual Cancer in patients with solid tumors. We hope that you will attend this 11th ISMRC meeting in MONTPELLIER and enjoy the opportunity to exchange information and establish long lasting collaborations during three days with researchers from academia and industry.

We will be very happy to welcome you in May 2018 in Montpellier !

http://www.ismrc2018.com

13–16 May 2018 20th annual Nanotech 2018 Conference & Expo (NANOTECH 2018)

Anaheim Convention Center, California, USA

Meet Us at The 20th annual Nanotech 2018 Conference & Expo (NANOTECH 2018) (Booth # 319), Anaheim, CA, USA, 13–16 May 2018

We will be attending The 20th annual Nanotech 2018 Conference & Expo (NANOTECH 2018), co-located with the TechConnect World Innovation Conference, Defense TechConnect Summit and Spring SBIR/STTR Conference. The event will attract more than 350 featured exhibitors and an expected crowd of more than 4000 attendees, including business executives, venture capitalists, politicians, s cientists and researchers from over 70 countries. Nanotech contains 38 symposiums and brings together specialists from a wide range of scientific fields, technology and business.

Representatives of the following open access journals will attend:

Sensors
Materials
Nanomaterials
Journal of Functional Biomaterials
Journal of Imaging
Sustainability
Fluids
Photonics
Electronics
Catalysts
Applied Sciences
Inventions
Diagnostics
Cancers
Journal of Low Power Electronics and Applications
Designs
Pharmaceuticals
C
Inorganics
International Journal of Environmental Research and Public Health
Machines
Pharmaceutics
Journal of Manufacturing and Materials Processing
Actuators
Robotics
Energies
Biosensors
Chemosensors
Membranes
Coatings
Micromachines

If you will also attend this conference, please feel free to stop by our booth (Booth # 319). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit:

https://www.techconnectworld.com/Nanotech2018/

24–25 May 2018 3rd Annual Advances in Immuno-Oncology Congress

London, UK

Oxford Global is proud to present the 3rd Annual Advances in Immuno-Oncology Congress taking place on 24–25 May 2018 in London, UK, featuring over 50 presentations in a revamped conference programme that ensures you will benefit from the latest case studies and high-level scientific debate.

Discussion ranges across a variety of therapeutic strategies, from the discovery of combination therapies to vaccines to checkpoint inhibitors. Further talks look at genomic approaches to cancer immunotherapy and the impact of growing microbiome research on immuno-oncology.

6 interactive streams:

  • Discovery of Immuno-Oncology Therapies
  • Translational Immuno-Oncology
  • Genomics in Cancer Immunotherapy and Precision Medicine
  • Preclinical Development: Screening, Assays and Modelling in Immuno-Oncology
  • Immuno-Oncology Therapeutics Approaches: Clinical Research and Clinical Trials
  • Microbiome in Immuno-Oncology

View the Agenda here: http://bit.ly/2oJlVB7

Key Speakers include Chief Executives and Directors from AstraZeneca, Merck, GlaxoSmithKline, Glycostem and many more. The two-day congress offers an interactive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions.

Free Pre-Congress Live Webinars

Novel Checkpoint Inhibitors & Strategies for Combined Modality Treatment
Hosted by Geert Mudde, Founder and Chief Scientific Officer, TYG Oncology Ltd.
Register today, for free: http://bit.ly/2mGZNmO

Personalised Medicine and Immuno-Oncology
Hosted by Agnete Fredriksen, Chief Scientific Officer, Vaccibody
Register today, for free: http://bit.ly/2rigNFh

Can’t make the dates? Still register and a copy of the webinar recording can be sent to you.

For further information about the programme, prices & discounts please contact a.fernandez@oxfordglobal.co.uk

http://bit.ly/2oJlVB7

7–8 June 2018 Oxford Global’s 19th Annual Drug Discovery Summit

Berlin, Germany

Join Oxford Global’s 19th Annual Drug Discovery Summit on the 7- 8th June 2018 in Berlin, Germany to explore the latest innovations pushing industry to new heights. This congress will cover such areas as innovation, enabling technologies, new modalities and novel drug targets as well as covering key areas such as phenotypic screening, genome based drug discovery and small molecule drug discovery.

Bringing together over 300 senior level peers, the congress is once again co-located with our 6th Annual Discovery Chemistry and Drug Design Congress. Delegates can expect to hear updates on discovery, medicinal and computational chemistry as well as medicinal chemistry in drug design. New for 2018 we’ll be including deep dive sessions on DNA encoded libraries as well as presentations on data visualisation, protein-protein interactions and protein degradation.

VIEW AGENDA: http://bit.ly/2mqWK5m

Drug Discovery Summit Streams:

  • Drug Discovery Innovation and Strategies
  • Successful Phenotypic Drug Discovery and Other High Content Screening Tools
  • Novel Drug Target Discovery for Immuno-Therapy, Autoimmune Diseases and Oncology
  • Genome Based Drug Discovery, Screening, Imaging & Target Discovery

Discovery Chemistry & Drug Design Congress Streams:

  • Discovery Chemistry, Medicinal and Computational Chemistry
  • Drug Discovery Enabled Technologies; DNA Encoded Libraries
  • Medicinal Chemistry and Drug Design: Novel Approaches

https://www.drugdiscovery-summit1.com/

7–8 June 2018 2nd Annual Microbiome Discovery and Development Congress

Berlin, Germany

Oxford Global is proud to present the 2nd Annual Microbiome Discovery and Development Congress, taking place on the 7-8th June 2018 in Berlin, Germany. The conference showcases world-class senior industry experts presenting case studies on the most exciting issues in the microbiome field, covering novel strategies in microbiome research, the latest therapeutic trends, and the challenges and opportunities involved in commercialising microbiome therapeutics.

View Agenda: http://bit.ly/2BOsODK

The congress will cover 2 areas focusing on:

  • Novel Strategies & Technologies for Microbiome Drug Discovery
  • Therapeutic Potential of the Microbiome
  • New for 2018! Workshop on commercialising microbiome therapeutics.

Further sessions will focus on subjects including bioinformatics, translational modelling, genomic approaches, IP concerns, investment in the microbiome, the gut-brain axis and autoimmune disorders. The two-day congress offers an interactive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions.

2018 Microbiome Webinar:      
Microbiome-Directed Therapeutics to tackle metabolic disorders        
Hosted by Sandrine Claus, Chief Scientific Officer, LNC Therapeutics     
Register for Free Now: http://bit.ly/2j0IqvO

For more information about our programme and to register for the congress, please contact Guillaume Alonso at g.alonso@oxfordglobal.co.uk.

http://bit.ly/2BOsODK

11–12 June 2018 2nd Annual Precision Medicine Congress

Munich, Germany

Join Oxford Global for the 2nd Annual Precision Medicine Congress, 11-12 June 2018, Munich as our panel of over 40 world class speakers discuss the latest regulatory updates, biomarker developments, information technologies and companion diagnostics for personalized therapies.        

View Agenda: http://bit.ly/2BF20WZ

Across two days, our event will bring together over 200 senior level attendees from academia, research institutes and pharma companies to discuss the current challenges and future perspectives of precision medicine. Over 40 presentations and case studies focusing on the key developments in precision medicine regulation, biomarkers, clinical development, digital technologies and diagnostics.

4 interactive streams:

  • Precision Medicine, Regulation, Reimbursement and Targeted Therapy
  • Precision Medicine, Biomarkers and Clinical Development
  • Precision Medicine: Genomics, Data analysis and Big Data Management
  • Precision Medicine and Diagnostics Development

2018 Live Webinar:

Precision Medicine & Cancer Genomics – Clinical And Pharmaceutical Applications
Hosted by Dr Honey Reddi, The Jackson Laboratory and Dr Michael Menden, AstraZeneca.
Register for Free Now: http://bit.ly/2F8bytZ

2017 Free Webinar Recording:

Clinical Utility of Genomic Testing 
Hosted by Elaine Lyon, Professor, University of Utah & Medical Director of Molecular Genetics, ARUP Laboratories.
Download for Free: http://bit.ly/2B3TOOO

For further information regarding prices and possible discounts, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call +44 (0)1865 248 455.

http://bit.ly/2BF20WZ

17–19 June 2018 20th Symposium on Infections in the Immunocompromised Host

Athens, Greece

We encourage all who are interested in the clinical practice and research on infections in immunocompromised host to attend the 20th ICHS Symposium in Athens, Greece June 17-19, 2018. Many symposia, plenary sessions, poster sessions will provide the attendee with opportunities to meet with outstanding leaders and clinical experts in the broad field of infectious diseases and immune-deficiencies while covering such diverse topics as new diagnostics,  infections in transplant recipients,  invasive fungal infections and resistance,  treatment of multi-resistant bacteria, infectious complications in immunocompromised children,  life-threatening infections and intensive care in neutropenic cancer patients ,antiviral and antifungal immune responses in compromised hosts,  prophylaxis and treatment of viral infections in immunocompromised hosts, and others.

http://www.ichs.org/2018-ICHS-Symposium

 

https://ichs2018.com/

11–12 October 2018 3rd Annual Biomarkers & Precision Medicine USA Congress

San Diego, USA

The 3rd Annual Biomarkers & Precision Medicine USA Congress is part of Oxford Global’s R&D US Series that features 3 outstanding programmes: our long-running 5th Annual Drug Discovery and Chemistry USA Congress, the 3rd Annual Biomarker & Precision Medicine USA Congress, and fast-emerging Advances in Immuno-Oncology USA Congress.

This event will host over 300 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

Over 40 presentations, case studies and panel discussions focused on the key issues in biomarker research, companion diagnostics, personalised medicine and clinical biomarkers

4 Interactive Streams:

  • Biomarkers in Drug Discovery and Development – Translation and Precision Medicine in Auto-Immune Diseases, CNS, Oncology, and Infectious Diseases
  • Personalised Medicine, Companion Diagnostics & Patient Testing. Biomarker Assay Validation and Patient Stratification
  • Innovations in Biomarker Research – Informatics, Data Management, Assay Development, Imaging Technologies
  • Biomarker in Clinical Development & Clinical Trials. Clinical Diagnostics, NGS & Genomic Markers and Genetic Testing

Free Pre-Congress Live Webinars 2018

Moving Diagnostic Biomarkers from Bench into the Clinic
Hosted by James Snider, CSO and President, Critical Diagnostics & Elizabeth Somers, Director Diagnostics, Morphotek

Register today, for free: https://bit.ly/2HOCyR7

Moving Biomarkers from Bench into the Clinic
Hosted by Xuemei Zhao, Senior Principal Scientist, Merck & Co., Inc & Qing Kang, Senior Scientist, Translational Medicine at Syros Pharmaceuticals

Register today, for free: https://bit.ly/2Kw62VC

Driving Precision Medicine and Advancing Big Data in Drug Development
Hosted by Stefan Scherer, Vice President, Global Head Correlative Science, Novartis

Register today, for free: https://bit.ly/2I3sGGq

For further information about the congress, registration fees and discounts available please contact a.saez@oxfordglobal.co.uk or click here: https://bit.ly/2feqU8H

Alternatively visit our website

https://bit.ly/2rd0SWE

11–12 October 2018 Advances in Immuno-Oncology USA Congress

San Diego, USA

Due to the success of the UK Advances in Immuno-Oncology event, Oxford Global are expanding this event to the USA. The USA Congress is the first of its kind and will feature over 20 presentations from leading heads of the Pharmaceutical industry and ensures you will benefit from the latest case studies and high level scientific debate.

Topic discussion ranges across a variety of therapeutic strategies, from CAR T cell therapies to microbiome in Immuno-Oncology and from assays and modelling in Immuno-Oncology to NK cell-based therapeutics.

Further talks look at approaches to clinical trial design and development and Translational Immuno-Oncology. To enhance the interactivity of the program, we have also introduced discussion opportunities through panels, roundtables and workshops on hot topics in this field.

Key speakers include Vice Presidents, Directors and Executives from leading pharmaceutical industries such as Pfizer and Atreca. The two day congress offers the opportunity to have scientific and business discussions, ensuring valuable networking and interactive sessions.

The conference will bring together over 100 senior industry experts and key opinion leaders in Immuno-Oncology.

For further information about the congress, please contact Danielle Dalby at d.dalby@oxfordglobal.co.uk alternatively download the agenda here >> https://bit.ly/2vrwiwW

Free Pre-Congress Live Webinar

The Role For TNFR2 In The Tumor Microenvironment

Hosted by Russell LaMontagne, Chief Executive Officer, Boston Immune Technologies and Therapeutics Inc

Highlights

  • The role TNFR2 tregs
  • TNFR2 Oncogene
  • Novel TNFR2 antibodies

Why should you attend this webinar?

  • Get an in-depth overview of the RWE landscape in Europe
  • Hear key updates from IMI EMIF
  • Discuss collaboration in this growing area

Register for free today

https://bit.ly/2L0l2LD

11–12 October 2018 5th Annual Drug Discovery USA Congress

San Diego, USA

Join Oxford Global’s 5th Annual Drug Discovery USA Congress taking place on the 11-12 October 2018 in San Diego. Across the two days, over 40 expert speakers will provide you with insights into the latest technological innovations and strategic approaches in drug discovery and drug chemistry.
View Agenda here.

The American biopharmaceutical research sector has been a world leader in the development of new medicines over the past 30 years and it continues to drive biopharmaceutical innovation. Our conference delivers an extensive look across the development process: from drug discovery innovation and strategies to computational chemistry and informatics for drug design.

The conference will feature over 40 presentations from leading heads of the pharmaceutical industry and ensures you will benefit from the latest case studies and high level scientific debate. Topic discussion ranges across the latest validation and optimisation strategies in neuroscience, cardiology and oncology. Further talks look at approaches to phenotypic and genomic drug discovery design, as well as novel approaches to drug design: AI-based design, DNA Encoded Libraries and protein-protein interactions.

Include 4 Streams:

  • Day 1 Stream 1: Drug Discovery Innovation and Strategies
  • Day 2 Stream 1: Phenotypic and Genomic Drug Discovery
  • Day 1 Stream 2: Computational Chemistry and Informatics for Drug Discovery
  • Day 2 Stream 2:
    • Part 1: Novel Approaches to Drug Design
    • Part 2: DNA Encoded Libraries
For more information contact g.alonso@oxfordglobal.co.uk or join the congress conversation on Twitter @DrugDiscoveryUS  or our LinkedIn Group: Drug Discovery & Development Network

https://www.oxfordglobal.co.uk/discoveryusa-congress/

9–11 April 2010 2nd Asian Oncology Summit

Bali, Indonesia

Dear Colleagues,

On behalf of the programme committees and organisers, I’d like to invite you to join us for the Second Asian Oncology Summit to be held in Bali, Indonesia, on April 9–11, 2010. We have assembled a tremendous 2.5 day schedule containing many regional and internationally renowned experts that we hope you will find compelling and informative.

The previous Summit was attended by approximately 800 delegates from throughout the Asia-Pacific region and beyond. Once again, we aim to provide a meeting that is relevant to practising physicians to help inform clinical practice and to optimise and improve patient management. The 2010 Summit includes five parallel programmes each dedicated to a different oncology specialty. Additionally, the Summit includes a number of educational and scientific sessions, plenary lectures, and discussions covering a broad range of subjects.

The theme for the 2010 event is optimising multidisciplinary care in Asia. In these economically constrained times, optimisation of healthcare has never been more important. The full integration and refinement of current knowledge, combined with new modalities and treatments that bring increased cost–benefits, has the potential to substantially improve treatment outcomes within a comparatively restricted healthcare environment.

I hope you find the conference details in this website, coupled with the wonderful location for the Summit, to be a persuasive reason to attend. Your active participation will continue to make the Asian Oncology Summit a unique and valuable contribution to medical practice in Asia.

I look forward to seeing you in Bali.

Dr David Collingridge
Editor, The Lancet Oncology
Chair, AOS 2010

http://www.asianoncologysummit.com/

25–27 April 2010 BIT\'s 3rd World Cancer Congress - Breast Cancer Conference

Shanghai, China

The BIT Life Sciences\' Annual World Cancer Congress is a China-based, interactive conference providing practicing oncologists with the latest research on epidemiologic, cancer molecular mechanisms, drug discovery, therapeutics development, diagnosis, clinical data, best practices, and new technologies that are directly applicable to the practice of cancer research and therapeutic discovery and development. The conference will provide participants a face-to-face platform to exchange ideas, share update breakthroughs and promising solutions to most important issues in the area.

Based on the program in previous years, this Breast Cancer Conference is our intention to focus on most relevant and controversial topics on biology, diagnosis and treatment of breast cancer, it will provide the participants on recent advices and current challenges in this area. Contents will be developed in Symposia, Plenary Lectures, co-current Sessions and Clinical Cases discussions. Leaders in the field will present in-depth presentations covering the multidisciplinary approach to the practice of breast cancer management and novel molecular-targeted therapies, with the incorporation of molecular and biologic translational studies from the laboratory into clinical practice.

http://www.bitlifesciences.com/Cancer2010/Breast/

7 May 2010 1st Annual Biliary Tract-Gallbladder Cancer Research Symposium

ASCO Conference Center, 2318 Mills Road, Alexandria, VA 22314, USA

Symposium Objectives

Utilizing a series of creative sessions to introduce and weave connections among the participants, and engage everyone’s imagination, the community will:

  • Frame the critical questions and knowledge gaps in bile duct and gallbladder cancers, identify research needs and opportunities, and
  • Create plans to work collaboratively and accelerate translational research in bile duct and gallbladder cancers.

Participants will be pre-assigned to multidisciplinary “Research Teams.” The program will include expert panel discussions, interactive exchanges to facilitate cross-discipline learning, and Research Team group work. During the final workshop, using a “purpose-to-practice design,” the community will create and develop plans to launch a Hepatobiliary Cancers Research Consortium.

Background information on bile duct and gallbladder cancers, information from other rare disease research initiatives, existing research recourses, and advocacy support will be posted on the Foundations’ websites prior to the Symposium as resources for participants.

Purpose:
Assemble stakeholders in bile duct and gallbladder cancers, including scientists, clinicians, research advocates and government partners. Create an inclusive community that will discover strategies to overcome traditional medical research silos. Develop a plan to accelerate translational research and improve the treatment and outcome for bile duct and gallbladder cancer patients.

Participants:
Basic scientists, pre-clinical scientists, clinicians, research advocates, and government agency partners who are involved in biliary tract and gallbladder cancers. Maximum 200 participants based on venue capacity.

http://www.canliv.org/invite.asp

8–11 July 2010 11th International Lung Cancer Congress

Rancho Palos Verdes, CA 90275, USA

Overview and Purpose

The purpose of the 11th International Lung Cancer Congress is to provide participants with an update on advances in the field of lung cancer, including biology, pathology, staging, personalized therapy, maintenance therapy, novel agents, and ongoing research in Cooperative Groups. Bringing key data from international oncology conferences to participants, the congress will emphasize the importance of personalized therapy and address other current topics of interest, such as maintenance therapy and novel targeted agents. State-of-the-art treatment for early-stage locally advanced and metastatic lung cancer will be discussed. In addition to non–small-cell lung cancer (NSCLC), the congress will address therapy for small-cell lung cancer (SCLC) and mesothelioma. A regular feature of the International Lung Cancer Congress is an update of research efforts from major Cooperative Groups from the United States, Europe, and Asia. The format of the meeting will include didactic lectures from internationally renowned leaders, debates and discussions on controversial topics, extensive panel discussions with case scenarios, multidisciplinary tumor boards, question-and-answer sessions, and afternoon translational workshops focusing on future strategies in development for the treatment of lung cancer.

Target Audience

This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of lung cancer are also invited to attend.

http://www.cancerlearning.com/index.cfm/fuseaction/conference.showOverview/id/5/conference_id/510

23–25 July 2010 2010 International Symposium on Advanced Biological Engineering (ISABE’2010)

Beijing, China

Biotechnology and Biological Engineering are coming into an exciting era as enabling technological platform for green industry, low carbon economy, health care and environment-benign society. In order to promote the international cooperation in above mentioned fields, the 2010 International Symposium on Advanced Biological Engineering (ISABE’2010) will be held in Beijing, China, from July 23rd to July 25th 2010. ISABE’2010 is jointly organized by Tsinghua University, China, Tokyo Institute of Technology, Japan, and coorganized by Biotechnology and Business. ISABE’2010 is also commissioned to bridge the academic research activities in biological engineering, biotechnology, nano-biotechnology, biomedical technology, environmental bioengineering, biofuels and microalga technology, and food biotechnology to various industrial practices, e.g., biomass-based chemicals, bioenergy, biopharmaceuticals, health care and environmental bioremediation. On behalf of the organizing committee,I am honored to welcome all of you to ISABE’2010. It will be a great pleasure to refresh our memories of the established ISABE in the past, share the up-to-date advances in both fundamental researches and engineering practices and to project the areas where we may contribute to our better life and planet. I look forward to meeting you in July and wish you all a pleasant and fruitful stay in Beijing.

http://www.isabe2010.com/

19–21 September 2010 Cancer and Metabolism: Pathways to the Future

Symposium Hall, Royal College of Surgeons of Edinburgh, Edinburgh, UK

To encourage discussion and interaction, we\'re combining outstanding and exciting science and a relaxed, pleasant environment. This meeting will be a great place for junior scientists to present their work. In order to divide, a cell needs both to increase its size, and to replicate its DNA – processes that are metabolically demanding, requiring large quantities of proteins, lipids and nucleotides as well as energy. In order to support such large-scale anabolism in rapidly-dividing cancer cells, substantial amounts of metabolic building blocks, particularly glucose and amino acids, must be made available to the tumor. Yet tumors are situated in a metabolically-challenging environment where blood supply, and the supply of oxygen and other nutrients that comes with it, is scarce. Therefore, tumor cells develop a remarkably different metabolism compared to the normal tissues from which they are derived. The extent to which metabolism plays a role in tumorigenesis cannot be overstated and drugs that can selectively target these processes are likely to at least delay, if not halt tumor progression. This workshop will cover all the major aspects of metabolic transformation in cancer and will highlight potential therapeutic approaches that target cancer-specific metabolic pathways. A vibrant and stimulating atmosphere will enable free discussion and cross-fertilization among all delegates.

http://www.abcam.com/index.html?pageconfig=resource&rid=12475

21–24 October 2010 42nd Congress of the International Society of Paediatric Oncology (SIOP)

Boston, MA, USA

Dear Members, Colleagues and Friends,

The theme of this year’s meeting, “Promoting International Collaboration in Pediatric Oncology,” represents SIOP’s mission of improving the global exchange of information and good practice in pediatric oncology. Dana-Farber/Children’s Hospital Cancer Care is honored to host this esteemed event in Boston, a special place in the history of pediatric cancer treatment.

Dr. Sidney Farber, while a pediatric pathologist at Children’s Hospital Boston, pioneered the development of chemotherapy and later founded Dana-Farber Cancer Institute. His break-through efforts in treating childhood leukemia set the stage for the evolution of the field internationally. In recognition of Dr. Farber’s advances and those which have followed, our state-of-the-art symposium on October 21 will focus on acute lymphoblastic leukemia and feature the expertise of Boston’s scientific community along with experts from around the world.

During your stay in Boston, be sure to take advantage of the many opportunities the city has to offer. This New England destination provides a unique blend of academic life, sophistication and diversity. I also invite you to come enjoy the beautiful autumn foliage and explore the city’s rich history by visiting its plethora of attractions.

From Boston, you can easily visit some of New England’s most scenic areas, including Cape Cod and the Coast of Maine, as well as visit many other great American cities, including New York, Philadelphia and Washington, D.C.

There’s no better opportunity for you to join your peers in learning about current research on treatments and practices eradicating pediatric cancers. Join us in Boston October 21-24, 2010, for an enlightening and unforgettable experience.

Sincerely,

Lisa Diller, M.D.
Chair, Boston Local Organizing Committee

http://www.siopboston2010.com/index.html

5–7 December 2010 Regenerative Medicine and Stem Cell 2010

Shanghai, China

Regenerative medicine and stem cell constitute a huge industry of medical technology and services, which is led to the Multi-disciplinary Cross Action and cooperation, such as life sciences, biological materials, computer control, bioinformatics, clinical medicine, and become a new driving forces of international bio-high-tech areas. And it has a perspective to form a biotechnology industry chain with the development of regenerative medicine industry as the center, which will be one of the high-tech industries with the huge potential in 21 century. RMSC is designed to offer a platform for promoting international exchanges and strengthening cooperation in science and technology involved in regenerative medicine and stem cell, which offered excellent opportunities for participants to get the lasted research progress, seek cooperation and gain the new ideas through the communicate with international experts.

http://www.bitlifesciences.com/rmsc2010/

27–29 March 2011 Cell Symposia: Metabolism & Aging 2011

Cape Cod, USA

For many decades, aging and metabolism were considered largely separate fields.
However, many of the most important discoveries are now occurring at the interface between the two. Interventions including caloric restriction, modulation in insulin and insulin like growth factor 1 (IGF-1), the sirtuin (sirt1) activator resveratrol, and the mammalian target of rapamycin (mTOR) have emerged as “protective” against the metabolic decline of aging, and have been shown to increase life span of several mammalian species. Elucidating how these pathways are interconnected and how they might be safely modulated to treat disease are among the most important challenges facing researchers in the coming decade.
This meeting aims to bring together scientists with interests in aging and metabolism to further explore how these fields intersect and to identify the most promising future directions. We will hear the latest data from leaders in the field about the key pathways at the level of the cell and the organ, across a range of contexts including model organisms, mammalian systems, and translational studies in primates and humans. Topics will also include how the signaling networks of metabolism and aging connect and communicate and how we can best make use of these connections to improve medicine and society.

Topic List

- Physiology & aging
- Aging from model organisms to humans
- Cell stress & organelle changes during aging
- Nutritional status and healthspan

Register by Friday 18th February 2011!

http://www.cell-symposia-metabolism-aging.com/index.html

14–16 April 2011 Kyoto Breast Cancer Consensus Conference (KBCCC) 2011 International Conference

Kyoto, Japan

This is an international medical congress endeavouring to reach a consensus regarding medical treatment methods between doctors and medical staff members involved in the treatment of breast cancer. The aim is to achieve better treatment results of breast cancer, which has recently been increasing rapidly, and for the improvement of QOL (Quality of life - degree of satisfaction mentally, physically, socially, culturally and intellectually on a daily basis)

www.kyoto-breast-cancer.org

1 December–3 November 2011 BC Cancer Agency Annual Cancer Conference

Vancouver, Canada

Join your colleagues from all oncology specialties at the BC Cancer Agency Annual Cancer Conference from December 1 to 3, 2011, at the Westin Bayshore Vancouver. This year’s theme is Improving Cancer Care through Partnerships, featuring: overseas projects; BC Cancer Agency participation in national, inter-provincial and regional initiatives; and, internal Agency collaborations across disciplines and platforms.

This year’s theme is Improving Cancer Care through Partnerships, featuring: overseas projects; BC Cancer Agency participation in national, inter-provincial and regional initiatives; and, internal Agency collaborations across disciplines and platforms.

http://www.bccrc.ca/bc-cancer-agency-annual-cancer-conference-december-1-3-2011

25–26 January 2012 The World Cancer Immunotherapy Conference: Challenges & Opportunities in Clinical Development, Clinical Trial Design & Commercialization

San Diego, CA, USA

The World Cancer Immunotherapy Conference is bringing together leading scientists and C-Level executives from across the globe to present research, case studies and viewpoints on various topics integral to a better understanding of the challenges and opportunities facing developers of therapeutic cancer vaccines.

With the recent commercialization of Provenge, an approval path has now been mapped out, albeit with major challenges in terms of uptake and reimbursement. Moreover, with other novel vaccines nearing approval, now is the time to revisit the successes and failures of this development program as well as the challenges that still lie ahead.

http://www.cancerimmunotherapyconference.com

26–27 January 2012 3rd National Conference: Renal and Bladder Cancer 2012

London, UK

Renal and Bladder Cancer 2012, assembles some of the most highly respected professionals in the fields of urology and oncology to discuss the current issues and challenges involved in the management of renal and bladder cancer patients.

Benefits of attending Renal and Bladder Cancer 2012:

  • Hear comprehensive overviews of the pathology, genetics and biomolecular markers of renal and bladder cancer
  • Gain updates into advances in diagnostic imaging of renal tumours and the latest clinical trials and research in bladder cancer
  • Increase understanding of the need to centralise renal cancer services to improve quality of care from the perspective of a clinician
  • Be updated on detection and prevention techniques of bladder cancer and the importance of active surveillance
  • Explore current and emerging surgical techniques
  • Evaluate cutting edge therapies including chemoradiotherapy
  • Participate in case study sessions with a panel of experts where delegates are invited to bring along their own examples of cases to add to the discuss
  • Take part in a practical exploration of the current issues in renal and bladder cancer to take back into your practice
  • Discuss and share ideas with leading practitioners in the field

http://www.mahealthcareevents.co.uk/cgi-bin/go.pl/conferences/detail.html?conference_uid=276

6–9 February 2012 Advances in Prostate Cancer Research

Orlando, FL, USA

CONFERENCE CO-CHAIRPERSONS:
Arul M. Chinnaiyan, University of Michigan, Ann Arbor, MI
Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY

http://www.aacr.org/home/scientists/meetings--workshops/special-conferences/advances-in-prostate-cancer-research.aspx

12–15 February 2012 4th International Conference on Drug Discovery and Therapy

Dubai, UAE

This unique international conference provides a platform for all pharmaceutical scientists, internists and primary care physicians to discuss and learn about all the important international breakthrough developments in drug discovery and on new therapeutics.

This conference organized by Eureka Science with the support of the Higher Colleges of Technology, UAE, focuses on the interdisciplinary fields of drug discovery, drug therapy and translational medicine.

After the overwhelming success of the previous conferences held in Dubai in February 2008, 2010 and 2011 (where many Nobel Laureates attended), the fourth conference promises to be a much larger event with over 500 talks delivered and 36 thematic sessions with poster presentations and an associated commercial exhibition.

Throughout the course of the four day conference, you will have the opportunity to both network and hear leaders from the international pharmaceutical, academic and clinical communities.

http://www.icddt.com

12–17 February 2012 Keystone Symposia: Cancer and Metabolism

Banff, Canada

Although altered glucose metabolism was first noted as a characteristic of tumor cells by Otto Warburg in the 1920s, the molecular underpinning for this observation did not begin to be appreciated fully until the past decade. This area has exploded over the last five years with the identification of extensive interactions of genuine tumor suppressor genes and oncogenes with metabolic control. The increased biosynthetic needs of tumor cells demand a reprogramming of cellular metabolism, which also creates increased energy demands and makes tumor cells more vulnerable to interventions targeting their metabolism. The goal of the Keystone Symposia meeting on Cancer and Metabolism is to bring together leaders in the fields of cancer and metabolic control with those studying the signaling pathways linking and governing each. The latest discoveries will be discussed as well as how this knowledge can be exploited to design future cancer therapeutics. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on Advances in Hypoxic Signaling: From Bench to Bedside, which will share a keynote address and a plenary session with this meeting.

http://www.keystonesymposia.org/12Q3

24–26 February 2012 8th European Congress on Hematologic Malignancies: From Clinical Science to Clinical Practice

Amsterdam, The Netherlands

In its eight year, the Congress encompasses hematologic malignancies, including myeloma, lymphoma, and leukemia, as well as discussions on screening, diagnosis and the latest management options. The focus of the 2012 Congress is to provide a forum to review state-of-the-art and present new data, as well as give attendees the opportunity to exchange ideas with world-renowned opinion leaders in the field.

http://www.imedex.com/

9–10 March 2012 13th European Congress: Perspectives in Lung Cancer

Amsterdam, Netherlands

It is our pleasure to invite you to the 13th European Congress: Perspectives in Lung Cancer, 9–10 March 2012, in Amsterdam, The Netherlands. Focusing on state-of-the art information on treatment and diagnosis, this Congress will provide attendees with valuable data for the management of patients with lung cancer.

Guided by an interactive format, Perspectives in Lung Cancer will not only provide a comprehensive overview of the most significant advances in lung cancer treatment, but will also leave attendees with valuable take home information. Lectures, meetthe- expert sessions, and panel discussions, will aid attendees in confirming their current practices, increase their knowledge of lung cancer and optimize their patient care.

Nearly 1,000 physicians, nurses, and other healthcare professionals attend Perspectives in Lung Cancer, annually, making it one of THE must attend lung cancer conferences. Past participants value the scope and depth of the information on disease biology, management, and research presented, and must return each year for the newest updates. As lung cancer research and treatment are ever-evolving, this comprehensive focus on the multimodal management of lung cancer in Europe is sure to be a rewarding educational experience for attendees to share.

We hope you will be able to join us for this valuable, educational two day meeting. Set against the backdrop of Amsterdam, a flourishing, industrious and cosmopolitan European city, which enjoys state-of-the-art technology and architectural developments, this Congress is not to be missed!

http://www.perspectivesinlungcancer.com

15–17 March 2012 3rd Quebec Conference on Therapeutic Resistance in Cancer

Montreal, Quebec, Canada

Following the success of previous editions, this international conference will bring together about 250 attendees, including oncologists, basic researchers, surgeons, pathologists, epidemiologists, ethicists, and other healthcare and research related professionals interested in therapeutic resistance in the clinical setting.

This conference is unique in that it is entirely dedicated to understanding and overcoming therapeutic resistance in cancer, an important dilemma encountered by scientists, clinicians and patients.

http://www.resistanceincancer2012.com/

27–29 March 2012 2nd Stem Cells for Drug Developers Meeting

Boston, MA, USA

The 2nd Stem Cells for Drug Developers meeting will bring together world leading experts from industry and academia to tackle the practical and scientific issues of developing stem cell-derived models.Learn, network and discuss: Harness the full potential of stem cells and improve your R&D process and pipeline efficiency.

http://stemcells-drugdevelopment.com/

18–21 April 2012 3rd European Lung Cancer Conference

Geneva, Switzerland

Organized by top academic experts in lung cancer and thoracic malignancies, this is THE thoracic CME Conference that you should attend: Lung cancer specialists from a wide range of disciplines will share information on the latest developments in basic, clinical and translational research.

Invitation by the Conference Scientific Chairs

In 2008 the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) joined forces to present the first edition of a biennial meeting addressing the scientific and educational needs of healthcare professionals treating malignant lung diseases. Now, following the success of the first two events, and on behalf of both societies, it gives us great pleasure to introduce the 3rd European Lung Cancer Conference (ELCC), 18–21 April 2012 in Geneva, Switzerland. We believe that a regular meeting on the topic of lung cancer plays a vital role in providing an updated overview of prevention, screening, diagnosis, treatment modalities and results of basic, clinical and translational research. This event should foster and enable fruitful interaction at a multidisciplinary level in order to strengthen an integrated approach to diagnosis and treatment of lung cancer.

We encourage you to save the date of this important European Conference and look forward to welcoming you to Geneva in 2012.

http://www.esmo.org/events/lung-2012-elcc.html

20–22 April 2012 The 9th Meeting of Asian Society for Neuro-Oncology

Taipei, Taiwan

Our goal is to meet and bring people together to ensure our profession remains at the cutting edge. The 2012 ASNO program will feature popular and informative special lectures, plenary sessions, poster sessions as well as educational courses focusing on neuropathology.

http://www.asno2012.org/

9–12 June 2012 International Symposium The Neutrophil in Immunity

Québec, QC, Canada

This will be the first conference ever held that focuses solely on neutrophils and their important role in immunity. The goal of this symposium is to bring together basic and clinician scientists, graduate students and post-doctoral fellows as well as technicians and research assistants who perform research in neutrophil biology or related fields. Several aspects of the program will also be of interest to the pharmaceutical and biotechnology industry. It is becoming increasingly apparent that the neutrophil participates in various aspects of immunity and we find it timely to bring together experts in neutrophil biology and related fields to discuss recent discoveries, exchange ideas as well as novel avenues of future investigation in neutrophil biology.

The main topics of the symposium include neutrophil functions and beyond; receptors, signalling and soluble mediators; cell-cell interactions; and neutrophils in the clinic. Several talks will be selected from submitted poster abstracts, providing an opportunity for senior students and postdocs to showcase their work.

http://www.neutrophil2012.ca/

12–15 June 2012 ESGAR 2012

Edinburgh, UK

In 2012 the Postgraduate Course, which always kicks-off the Annual Meeting, will focus on luminal gastrointestinal imaging, reflecting the UK’s long and illustrious heritage in that field.

http://www.esgar.org/

14–17 June 2012 WCIO 2012: World Conference on Interventional Oncology

Chicago, Illinois, USA

The World Conference on Interventional Oncology is the largest interventional oncology meeting in the United States. More than 500 attendees are expected to attend WCIO 2012, which is scheduled 14 - 17 June in Chicago, Illinois, USA.

http://www.wcio2012.org/p/cm/ld/fid=1

14–15 June 2012 Apoptosis and Cancer

Cambridge, UK

A failure of cells to undergo apoptosis is a common feature of many cancers. During the last 20 years, work in many laboratories has led to the identification and understanding of many of the key players involved in apoptosis. This conference will highlight recent developments in our current understanding of the cellular role of some of these proteins as well as how our knowledge of the basic cellular apoptotic pathways is being used to develop targeted cancer chemotherapeutic agents. Particular attention will be paid to novel agents  that are currently in development or early clinical trials to exploit our understanding of the Bcl-2 family, the p53 family, death receptors and  inhibitor of apoptosis proteins (IAPs).  Discussion sessions will involve members from academia as well as industry.

http://www.abcam.com/index.html?pageconfig=resource&rid=14653

18–20 June 2012 Melanocytes and melanoma – from basic science to clinical application

Malmö, Sweden

Key players in the field of melanocyte and melanoma research are invited to present their latest work on topics ranging from melanocyte development, to targeted melanoma therapy. It will be an excellent opportunity to get an update on the most recent advances in these fields of research.

http://www.melanoma2012.org/index1.asp?siteid=1&pageid=1

27 June–1 July 2012 30 Years of Wnt Signalling

Egmond aan Zee, The Netherlands

This conference will celebrate the 30th anniversary of the identification of Wnt-1 by bringing together researchers who founded
the field and the young scientists who will be responsible for its future.

http://events.embo.org/12-wntsignalling/

28–30 June 2012 MASCC/ISOO 2012 International Symposium on Supportive Care in Cancer

New York, USA

The MASCC/ISOO 2012 International Symposium focuses on the clinical management of supportive care in oncology. It is essential that all oncology specialists, care-givers and cancer policy makers are fully updated as to the latest available physical and psychological treatments to prevent, control, or relieve complications and side effects of cancer and its treatments — including antineoplastic approaches. This advanced scientific oncology congress is endorsed by the leading Multinational Association of Supportive Care in Cancer and the International Society of Oral Oncology.

http://www2.kenes.com/mascc/pages/home.aspx

28–29 June 2012 WIN 2012 Symposium

Paris, France

The Worldwide Innovative Networking (WIN) Consortium invites you to attend the WIN 2012 Symposium, to be held in  Paris, June 28-29, 2012. This symposium will be the next in the successful series of annual meetings dedicated to personalized cancer medicine. The WIN Consortium was created to accelerate the pace and reduce the cost of translating effective cancer treatments to the bedside. The WIN 2012 Symposium provides an open forum for discussion between all stakeholdere in cancer biomarkers and therapeutics development and great networking opportunities for everyone involved in improving cancer patient care at the level of the individual patient.

The main theme of the 2012 symposium, Efficacy of biomarkers and personalized cancer therapeutics, will be elaborated in various plenary sessions, bringing togeteher a unique assembly of high-ranking experts from academia, industry and regulatory agencies wordwide as speakers and moderators.

http://www.winconsortium.org/symposium.jsp?id=300

17–20 July 2012 2nd Annual Workshop on Cancer Systems Biology: Tumor Metronomics - Timing and Dose Level Dynamics

Boston, Massachusetts, USA

This workshop will address the problem of evaluating the metronomics concept from a quantitative, 'systems' perspective. We will focus on tumor context - how do cell-cell interactions modify cancer dynamics, and how we might render our responses in quantitative terms that are testable, and most importantly, predictive. More specifically, the workshop will try to address the problem of chemotherapeutic dose and frequency from a control-theoretic standpoint, focusing on each individual response targets in turn: 1) angiogenesis, 2) stem cell response, and 3) immune response.

http://www.cancer-systems-biology.org/ccsb/EO/workshops/workshop2012.html

11–14 September 2012 11th International Conference of the International Mesothelioma Interest Group

Boston, Massachusetts, USA

Building on the success of previous meetings, the Conference will feature workshops, debates, poster sessions and breakout symposia including topics such as immunology, immunotherapy, imaging, pathology as well as surgical pitfalls and challenges. The Conference will provide the ideal forum to stimulate ideas and establish collaborations as well as to initiate intense discussions about surgery, pathology, new treatments, relevance of biological data and animal models. Poster viewing opportunities and interactive sessions will foster communications between delegates. Another scientific emphasis will be molecular biology and the sequencing of the mesothelioma genome.

http://www.imig2012.org/

25–26 September 2012 Molecular Diagnostics World Congress

San Diego, CA, USA

The Molecular Diagnostics World Congress and exhibition will be held in San Diego, CA, USA.

http://selectbiosciences.com/conferences/index.aspx?conf=MDWC2012

15–16 November 2012 International Conference of National Strategies for TORCH, Chlamydia trachomatis and human papilloma virus

Kiev, Ukraine

The conference will help to develop national strategies for early detection, control and treatment of kompleksa TORCH, Chlamydia trachomatis and human papillomavirus. The conference program will address the latest clinical diagnostic, economic and scientific achievements in the practical and scientific medicine to meet the needs and interests of immunologists, allergists, laboratory specialists, gynecologists, Dermatovenereologists, infectology, microbiologists, health professionals. In addition, a large industrial exhibition in the new and interesting way.

http://nbscience.com/international-conference-of-national-strategies-for-kompleksa-torch-chlamydia-trachomatis-and-human-papilloma-virus/

5–6 March 2013 Cancer Progress

New York City, USA

Since 1985, Cancer Progress has provided pharmaceutical and biotech executives the opportunity to review and discuss significant contemporary issues in oncology. During two days of presentations and panels, world-class researchers and key executives offer incisive overviews and candid assessments of today’s most important topics.

http://www.cancerprogressbydh.com/

20–23 April 2013 7th Conference on Experimental and Translational Oncology

Portoroz, Slovenia

The Association of Radiology and Oncology, COST and Co-chairs invite you to participate at the 7th Conference on Experimental and Translational Oncology – CETO, which will be held in Portoroz, Slovenia, April 20-24, 2013. The aim of the Conference is to promote the achievements of basic and clinical investigators on mechanisms of tumor initiation, development and progression as well as the introduction of new strategies for detection, prevention and treatment of cancer.

http://www.ceto.si/

29–31 May 2013 The Bone Marrow Niche, Stem Cells, and Leukemia: Impact of Drugs, Chemicals, and the Environment

New York City, USA

Over 20,000 Americans are diagnosed each year with bone marrow failure syndromes. Environmental, chemical, and genetic factors have been linked to the development of lymphomas, leukemias, and myelodysplastic syndromes (MDS). Additionally, some anti-cancer drugs have been shown to themselves induce DNA damage and secondary cancers. In light of increasing societal exposure to toxic environmental agents that may be carcinogenic, including chemicals and pharmaceuticals, we face the potential for a rise in the incidence of bone marrow failure and malignancy. In order to better understand leukemia it may be necessary to examine it from the perspective that it is an environmental disease.

http://www.nyas.org/Events/Detail.aspx?cid=b4c60844-7a53-45d6-8640-9419c6353529

3–6 June 2013 Drug Discovery & Therapy World Congress 2013

Boston, MA, USA

This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss and learn about important international breakthrough developments in drug discovery and on new therapeutics. The focus of the conference will be on the interdisciplinary fields of drug discovery, drug therapy and translational medicine. A similar series of conferences have been held by the organizers in the UAE over the last several years. These events have been highly successful and many top international scientists, including over 22 Nobel Laureates, have presented their work.

http://www.ddtwc.com/index.php

20–21 June 2013 The British Gynaecological Cancer Society Annual Scientific Meeting 2013

Belfast, Northern Ireland

The British Gynaecological Cancer Society Annual Scientific Meeting 2013 promises to serve as the central meeting point to discuss the latest advances and treatments in gynaecological oncology. Being held in conjunction with the Irish Gynaecological Cancer Society (IRGCS), BGCS 2013 is an influential platform for professionals from the specialties of obstetrics, gynaecology, oncology and radiology to network with colleagues from the UK and across Europe.

http://bgcsconference.com/

27–29 June 2013 The MASCC/ISOO 2013 International Cancer Care

Berlin, Germany

The MASCC/ISOO 2013 International Cancer Care Symposium will facilitate a fruitful exchange on the clinical management and basic science aspects of supportive care in oncology. This cancer care symposium will present a comprehensive scientific program presented by acclaimed speakers.

http://www2.kenes.com/mascc2013/pages/home.aspx

23–24 September 2013 Clinical Genomics for Cancer Diagnostics

Boston, MA, USA

The Inaugural Clinical Genomics for Cancer Diagnostics meeting will look at novel diagnostic tools and techniques, evaluate their benefit to patient outcome, and focus on steps to implementation. Hotspot testing will be compared to comprehensive genome profiling and emerging technologies will be explored. Considerations for molecular test development, result reporting, and patient stratification will be also addressed. Using genomic information in cancer management presents many operational challenges, but also offers an unprecedented opportunity to take the trial and error out of cancer treatment.

Topics Include:

  • Interrogating Cancer Genes with NGS-Based Approaches
  • Genotyping Technologies
  • Data Interpretation
  • Moving from Technology to Patient Treatment
  • The Evolving Role of the Patient

http://www.healthtech.com/Cancer-Genomics/

14–15 October 2013 Oncology Clinical Development Congress 2013

Manchester, UK

It is estimated that each year 12.7million people are diagnosed with cancer across the globe. Our experts will discuss the latest advances in the development of targeted therapies and explore their translation into clinical trials.

http://www.oncologyclinicaldevelopment-congress.com/

19–22 October 2013 18th International Meeting Of The European Society of Gynaecological Oncology (ESGO)

Liverpool, UK

The European Society of Gynaecological Oncology’s annual
International Meeting is Europe’s landmark meeting on Gynaecological Oncology and offers professionals an excellent opportunity to discover the latest medical and scientific information on gynaecological cancer treatment and care.

http://www2.kenes.com/esgo18/Pages/Home.aspx

27–31 October 2013 15th World Conference on Lung Cancer

Sydney, Australia

Building on the success of previous conferences, the theme of the 2013 meeting ‘Achieving Optimal Outcomes Through Multidisciplinary Care’ will reflect the need for collaboration and cooperation in producing the best possible outcomes in the treatment of lung cancer. It is also a reflection of the nature of the International Association for the Study of Lung Cancer which welcomes and encourages the participation of individuals from a wide range of professional backgrounds in its Conferences.

http://www.2013worldlungcancer.org/

3–6 November 2013 13th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases

San Juan, Puerto Rico

The conference series on Bioactive Lipids in Cancer, Inflammation and Related Diseases was started in 1989 when its first conference was held in Detroit, Michigan. Subsequent meetings were held around the globe with the next conference scheduled for November 3 - 6, 2013 in San Juan, Puerto Rico.

The previous biennial conferences have been immensely successful in highlighting data from research at the cutting edge of science on the role of lipid mediators in various physiological and pathological processes. The goal of this meeting series is to promote the exchange of ideas between scientists of diverse backgrounds from around the world.  And to provide a forum for the dissemination of the latest scientific information on bioactive lipids in health and disease as it relates to cancer, inflammation and inflammation induced diseases such as cardiovascular, diabetes, psoriasis, and Alzheimer's.

http://bioactivelipids.org/

6–8 November 2013 3rd Cancer Epigenetics

San Francisco, CA, USA

GTC’s 3rd Cancer Epigenetics Conference, one of two parallel tracks of the 2nd Cancer Summit – Novel Approaches to Drug Discovery on November 6-8 in San Francisco, CA, is the only cancer epigenetics conference that brings together leading experts from the industry and academia to collaborate on the latest cutting edge research on novel mechanisms, therapeutics, drug discovery, developments, biomarkers and diagnostics for cancer epigenetics.

http://www.gtcbio.com/conference/cancer-epigenetics-overview

29 November 2013 Best of Oncology 2013 East Conference

Toronto, Ontario, Canada

Following the success in last year’s Best of Oncology East Conference, we are happy to announce that we will be hosting the 3rd Annual Best of Oncology East Conference on November 29th, 2013 at the Westin Prince Hotel! Last year we had over 200 participants for this great full day event that covered 9 different tumour topics. We are thrilled to offer this event again this year and look forward to seeing many familiar faces along with many new faces.

During the event, sponsors will have the opportunity to exhibit and participants can view the exhibits and mingle with fellow participants. There will be a registration desk setup in order to assist with any questions or concerns that participants or sponsors might have, along with providing name tags and handouts for the conference.

http://www.oncologyeducation.com/conferences/welcome-to-the-best-of-oncology-2013-east-conference.html

5–7 January 2014 Signalling and Acquired Resistance to Targeted Cancer Therapeutics

Cambridge, UK

Tumour cells rapidly evolve to acquire resistance to new, targeted therapeutics such as protein kinase inhibitors. Understanding such ‘acquired resistance’ has obvious clinical relevance but also reveals the plasticity of signalling pathways and their ability to remodel through feedback and cross-talk. This meeting will highlight advances in understanding how tumour cells adapt to inhibition of specific signalling pathways and the role this plays in acquired resistance.

Topics:

  • RAF-MEK-ERK signalling
  • Tyrosine kinases and their inhibitors
  • TOR/PI3K inhibitors
  • Kinome reprogramming
  • Cell survival/cell death signalling
  • Systems and computational biology approaches

http://www.biochemistry.org/Conferences/AllConferences/tabid/379/MeetingNo/SA154/view/Conference/Default.aspx

9–11 February 2014 11th International Symposium on GnRH: The hypothalamic-pituitary-gonadal axis in cancer and reproduction

Salzburg, Austria

On behalf of the Organizing Committee, I take pleasure in inviting you to the 11th International Symposium on GnRH – The hypothalamic-pituitary-gonadal axis in cancer and reproduction, which will be held in Salzburg, Austria, February 9-11, 2014.

Human gonadotrophins have been in clinical use for over 50 years. This symposium will evaluate lessons learnt from the use of gonadotrophins, GnRH analogues and other peptides, and discuss future trends and changes ahead.

http://www2.kenes.com/gnrh2014/Pages/Home.aspx

19–21 March 2014 9th European Breast Cancer Conference (EBCC-9)

Glasgow, Scotland

Our renowned series of European Breast Cancer Conferences (EBCC) provide a unique multidisciplinary setting for all professionals with a common interest in breast cancer to navigate, discuss, inform and educate themselves about this evolving disease landscape; to debate and deliberate about new data and developments; and to establish what it means for patient treatment and care. Even more importantly, the 9th European Breast Cancer Conference (EBCC-9), the largest Breast Cancer Conference outside the USA, will enable participants to implement the new findings into their daily practice, making a tangible difference for their patients. This will be the core focus of EBCC-9, in Glasgow, Scotland from 19 to 21 March, in 2014.

http://www.ecco-org.eu/Events/EBCC9.aspx

9–12 April 2014 7th International Conference: HPV, Polyomavirus, UV in Skin Cancer

Novara, Italy

The 7th International Conference on “HPV, Polyomavirus and UV in Skin Cancer” will be held in Novara, Italy, April 9-12, 2014. It will bring together leading scientists that will discuss the latest research developments in UV & Virus – related skin cancer. Our goal is to serve as a forum for the exchange of state-of-the-art information on human papillomavirus (HPV) and polyomavirus (HPyV) research and its future perspectives following up on the proceedings of the 6th International Conference of Berlin in 2012.

http://hpvpolyomanovara2014.it/

26–30 May 2014 15th World Congress for Cervical Pathology and Colposcopy

London, UK

The 15th World Congress for Cervical Pathology and Colposcopy (IFCPC 2014) will promote the best possible standards of Colposcopy around the world with the goal of guaranteeing that women everywhere receive excellent care. IFCPC will feature structured training sessions that will improve clinician competence, performance and patient outcomes through educational activities focused around the study, prevention, diagnosis, and management of HPV and genital tract diseases. By placing the latest research and techniques at the service of health care professionals on every continent, the congress seeks to bridge the gap between theory and practice.

The BSCCP and 32 National Societies represented by the IFCPC, this congress will provide the perfect forum for sharing international knowledge and experience, dealing with core issues in cervical pathology and colposcopy. Meet the best and brightest minds working in the field at IFCPC 2014.

http://ifcpc2014.com/

30 May–3 June 2014 2014 ASCO Annual Meeting

Chicago, Illinois

Attendees of the 2014 Annual Meeting will find cutting-edge scientific presentations and comprehensive educational content.

The ASCO Annual Meeting brings together more than 25,000 oncology professionals from a broad range of specialties, making it an excellent venue for exploring the theme of the Meeting — "Science and Society." Prospective attendees can familiarize themselves with some basic information, including:

  • The various session types that will take place at the Annual Meeting
  • The Cancer Education and Scientific Program Committees

http://am.asco.org

28 June–2 July 2014 16th International Symposium on Pediatric Neuro-Oncology

Singapore

The International Symposium on Pediatric Neuro-Oncology (ISPNO) is the major biennial global meeting of the multi-disciplinary international community of professionals involved in the research, diagnosis, treatment and rehabilitation of infants and children with brain tumors.

http://www.ispno2014.com

7–8 July 2014 5th Cancer Targets & Therapeutics

Boston, MA

The 5th Cancer Targets & Therapeutics Conference, taking place on July 7-8, 2014 in Boston, MA will continue to be a premier event for translational researchers, preclinical scientists and managers, and those carrying out early phase clinical trials, working to identify and exploit advances in the field in order to deliver products with a meaningful clinical impact.

http://www.gtcbio.com/conference/cancer-targets-overview

10–12 September 2014 MAP Kinases

Vilnius, Lithuania

Join this conference and discover new and upcoming trends of map kinases, network with international experts from the leading countries in biosciences and learn about advances and potential of Lithuanian biotech institutes, universities and companies.

http://www.lsb2014.com/en/events/map-kinases/about/

16–18 October 2014 4th International Breast Cancer Prevention Symposium

Purdue University, West Lafayette, USA

The goal of this symposium is to bring together global public  health actors, advocates, and researchers on breast cancer prevention, to  discuss the impact of environmental factors such as foods, stress, exercise on the genome.

http://www.purdue.edu/breastcancer/

8–11 November 2014 15th Biennial Meeting of the International Gynecologic Cancer Society

Melbourne, Australia

The 15th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2014), being held in the dynamic city of Melbourne, Australia, November 8-11, 2014, is your opportunity to discuss and debate the latest medical and scientific information, treatment and care in the field of gynaecologic oncology.


Building on the success of previous IGCS Meeting, this innovative educational forum will enable you to learn unique approaches to best care practices, reconnect with colleagues, and establish new professional contacts among the world's most noted experts in the field.

http://www2.kenes.com/igcs/Pages/home.aspx

3–6 December 2014 2014 World Cancer Congress

Melbourne, Australia

The World Cancer Congress programme will cover the hottest and most current topics of cancer control, from prevention and screening, to cancer diagnosis and treatment, cancer survivorship and palliative care, as well as cancer control systems.

http://www.uicc.org/convening/world-cancer-congress/2014-world-cancer-congress-melbourne

9–13 December 2014 San Antonio Breast Cancer Symposium

San Antonio, Texas, USA

The 2014 San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the shared mission of the organizations to advance progress against breast cancer.

http://www.sabcs.org

9–13 December 2014 2014 San Antonio Breast Cancer Symposium

San Antonio, TX, USA

"An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer."

http://www.sabcs.org/

27 February 2015 Best of Oncology West 2015 Conference

Vancouver, Canada

Objectives include:

• To discuss the pivotal oncology trials presented in the different disease sites

• To review the current standard of care for key malignancies

• To discuss the current controversies in the management of specific cancers

http://www.oncologyeducation.com/events/upcoming-events/best-of-oncology-west-2015/conference-home/

18–20 March 2015 Biomarker Summit 2015

San Diego, CA, USA


A wide variety of important topics will be covered including biomarker identification, validation, and translation strategies, bioinformatics and systems biology approaches to personalized medicine, big data analytics and management, regulatory and reimbursement trends, companion diagnostics development, and much more. Through scientific presentations, case studies and panel discussions, these areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector.

https://www.gtcbio.com/conferences/biomarkers-summit-overview

11–12 April 2015 WORLD CONGRESS on ANGIOGENESIS 2015

Boston, MA, USA

This event, organized by The Angiogenesis Foundation, is bringing together world leaders in angiogenesis research and treatment across multiple disciplines. Join us and converge on exciting breakthroughs, new concepts, bold ideas and tipping points across angiogenesis fields.

http://angioworldcongress.com/

27–29 April 2015 Stem Cell Summit 2015

Boston, MA, USA

Recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, immunotherapy, stem cell reprogramming, regulatory policies regarding stem cell research, and manufacturing will all be discussed. Business opportunities, challenges, and potential strategies for overcoming these challenges will also be addressed. Come join us to learn what categories of companies are currently commercially viable, how they're being funded, and what kind of strategic relationships are available within the industry!

https://www.gtcbio.com/conferences/stem-cell-summit-overview

5–8 May 2015 European Pharma Summit

Berlin, Germany

This event seeks to create a forum for colleagues across multiple disciplines, as well as from both private and public sectors, to gather and exchange ideas. Over 400 delegates from pharmaceutical organization, biotech companies, and leading academic institutions will gather over the course of four days to listen to presentations on the hottest topics in drug discovery and network with both new and old colleagues.

https://www.gtcbio.com/conference/european-pharma-summit-overview

24–29 May 2015 International Conference on Cytokine Signaling in Cancer

Chania, Crete, Greece

We feel that there is a specific unmet need for a summit on the signaling mechanisms that mediate cancer-related function of cytokines either in cancer cells or within the microenvironment or associated with cancer noxias such as DNA damaging agents, infectious disease or aging related processes. The proposed Aegean conference on the cytokine signaling in cancer should fill this gap and bring together outstanding experts in the area and enable exchange the information and ideas important for improving our understanding of cancer etiology and pathogenesis. This should pave roads towards design of novel anti-cancer therapeutic modalities.

http://www.aegeanconferences.org/src/App/conferences/view/94

27–30 May 2015 Advances in Brain Cancer Research

Washington, D.C., USA

This AACR Special Conference will discuss novel approaches in the treatment of brain cancers; the role of mathematics and computational modeling in the analysis of large amounts of data; and the development of animal models that faithfully recapitulate human brain cancers and their use in pre-clinical studies.

http://www.aacr.org/home/scientists/meetings--workshops/special-conferences/advances-in-brain-cancer-research.aspx

29 May–2 June 2015 2015 ASCO Annual Meeting

Chicago, IL, USA

The ASCO Annual Meeting brings together more than 25,000 oncology professionals from a broad range of specialties, making it an excellent venue for exploring the theme of the Meeting—"Illumination and Innovation."

http://am.asco.org/

11–12 June 2015 Molecular Diagnostics Summit

San Diego, CA, USA

Join leaders from pharmaceuticals, healthcare organizations, and academia to learn about and discuss new emerging technologies, reimbursement, clinical utility, validation, applications, and what the future holds for the diagnostics areas listed below:

  • Cancer Markers & Liquid Biopsies Conference
  • Pathology Diagnostics Conference
  • Companion Diagnostics Conference
  • Point-of-Care Diagnostics Conference

https://www.gtcbio.com/conferences/molecular-diagnostics-summit-overview

28–30 August 2015 ESMO Academy 2015

Oxford, UK

The purpose of this highly interactive meeting is to give a general but indepth update about the major topics in medical oncology. The meeting is specifically designed for professionals who intend to take the ESMO Examination, medical oncologists in training, and professionals in need of a refresher course.

http://www.esmo.org/Conferences/ESMO-Academy-2015

3–4 September 2015 Cancer diagnosis & Therapy Congress

London, UK

MarketsandMarkets Conferences (MnM Conferences) is delighted to announce the inaugural Cancer Diagnosis & Therapy Congress to be held on September 3-4, 2015 London, UK focusing on the theme of “Advancement in Cancer diagnosis, treatment and challenges in organ specific cancer treatment”. The two day program will address key concerns such as cancer Immunotherapy, molecular targeted therapy, metabolomics in cancer tumour assessments & profiling, nanotechnology in cancer therapy, hormone therapy, stem cell Transplantation, surgical oncology, epigenetics, cancer genomics, cancer biomarkers, bio banking, non-invasive cancer diagnostics, organ specific cancers, cancer epidemiology and clinical trial in cancer research. Major segments to be discussed : • Advanced Cancer Detection, Diagnosis Methods and Technologies • Novel Approaches to Cancer Therapy • Emerging Challenges in Organ Specific Cancers Research

http://www.mnmconferences.com/cancer-diagnosis-therapy-congress.html

25–29 September 2015 European Cancer Congress 2015 (ECC 2015)

Vienna, Austria

The European Cancer Congress (ECC 2015) – recognised as one of the premier, multidisciplinary cancer meetings in Europe – will combine the united efforts to continue improving the prevention, diagnosis, treatment and care of cancer patients.

http://www.esmo.org/Conferences/European-Cancer-Congress-2015

8–9 October 2015 6th InterAmerican Oncology Conference

Buenos Aires, Argentina

The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies, and emerging treatments in early development. The major emphasis will be on clinical aspects of cancer treatment in the 21st century with discussion of significant scientific advances underlying the novel approaches still in preclinical development.

http://www.oncologyconferences.com.ar/

9–10 October 2015 Hallmarks of cancer: Focus on RNA

Institut Curie - Amphithéâtre Constant Burg, Paris, France

Accumulating evidences support the importance of RNA biology in the hallmarks of cancer. Post-transcriptional steps of gene expression (pre-mRNA splicing and polyadenylation, mRNA stability, translation and modifications) as well as the functions of non-coding RNAs are increasingly diverse. It is therefore challenging to comprehend this complexity in the context of cancer.

The internationally renowned experts invited to this symposium will present the recent advances in our understanding of RNA biology in cancer. This will be complemented by at least 10 selected talks and 60 poster presentations.

The symposium is intended to bring together RNA and cancer biologists. It is expected that the small size of the attendance (max 120) will foster stimulating discussions that will lead to innovative collaborations.

https://www.weezevent.com/curie-cancer-rna

13–16 April 2016 8th General Assembly and International Conference of Asian Pacific Organisation for Cancer Prevention (APOCP8)

Brisbane, Australia

The 8th General Assembly and International Conference of Asian Pacific Organisation for Cancer Prevention (APOCP8) will provide a platform for presentations, discussion and planning across the full spectrum of cancer prevention – from health promotion, prevention, diagnosis, treatment, management and survivorship.

The theme for the meeting is: Foundations of cancer control in the Asia Pacific: Research Program development/ Practical interventions

http://www.apocp8.org/

5–10 June 2016 4th International Conference on Tumor Microenvironment and Cellular Stress

Rhodes, Greece

4th International Conference on Tumor Microenvironment and Cellular Stress: Signaling, Metabolism, Imaging and Therapeutic Targets

www.aegeanconferences.org

6–8 July 2016 Molecular Diagnostics Summit 2016

Boston, MA

The summit will bring together our usual balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the various topics below:
2nd Cancer Markers & Liquid Biopsies:
The role of cancer markers is significant towards the diagnosis, prognosis, and surveillance of a patient. Understanding markers and characterizing circulating elements with the latest technologies aid our progress toward the future of better personalized cancer care. Leaders in industry and academia will discuss platforms for isolating and studying CTCs. Technologies such as next generation sequencing and digital PCR are gaining momentum in these research areas. This meeting will also discuss biomarker sensitivity, stability, validation, and how we can use markers to follow up with patients and improve the quality of life.
Precision Medicine:
There is a huge drive in Precision Medicine as it integrates research and clinical practice to build a knowledge base that can better guide individualized patient care. At a crucial time, where there are efforts to scale up population-based genome sequencing and integrate it with clinical data, this meeting will discuss the progress towards the implementation of precision medicine. This conference will discuss the future of healthcare, strategies and technologies for successful implementation, precision medicine beyond oncology, integrating and interpreting personal genomics, big data, bioinformatics, and overcoming challenges in the commercialization of precision medicine.
Digital PCR & qPCR:
There has been a push to find a faster and a more efficient way to optimize the quantification of nucleic acids. In the past, quantitative polymerase chain reaction (qPCR) has been the best way to measure the relative amplification of PCR in real time. In more recent years, digital PCR has become a newer method of PCR quantification that can result in absolute quantification, increased sensitivity in samples, more controllable precision, and multiple partitions of the same sample. This meeting will discuss the newest developments in digital PCR and qPCR in relation to how PCR can be used the molecular diagnostics field.

https://www.gtcbio.com/conferences/molecular-diagnostics-summit-overview

12–13 July 2016 Extracellular Vesicles 2016

Cambridge. UK

Clarifying contradictions in the characterization and isolation of extracellular vesicles, and identifying where the most promising opportunities for therapeutics and diagnostics lie, is proving to be one of the most attractive challenges of the decade for the global biomedical community

https://selectbiosciences.com/conferences/index.aspx?conf=EVE2016

12–13 July 2016 Extracellular Vesicles 2016

Cambridge, UK

SELECTBIO is thrilled to announce that Extracellular Vesicles: Biology & Therapeutic Potential will be taking place on 12 - 13 July, 2016 in Cambridge, UK.

Clarifying contradictions in the characterization and isolation of extracellular vesicles, and identifying where the most promising opportunities for therapeutics and diagnostics lie, is proving to be one of the most attractive challenges of the decade for the global biomedical community.

We welcome you to take this opportunity to interact with this community and benefit from the expert knowledge of academic and industry leaders who are investigating these vital mediators of intercellular communication as potential targets for therapeutic innovation.

https://selectbiosciences.com/conferences/index.aspx?conf=EVE2016

1–2 November 2016 Cancer Immunotherapy & Biofluid Biopsies 2016

Boston, USA

Cancer Immunotherapy & Biofluid Biopsies 2016 brings together the key opinion leaders in the immunotherapy and tumor immunology fields to address the most up-to-date strategies for immune therapy and means by which immunotherapies may be rationally-combined with more traditional anti-cancer therapeutics. This field is converging with biofluid biopsies/liquid biopsies and therefore this conference brings together these two disciplines as they are co-evolving.

http://selectbiosciences.com/conferences/index.aspx?conf=CIBB2016

6–9 November 2016 NCRI Cancer Conference

Liverpool, UK

The NCRI Cancer Conference showcases the latest basic, translational and clinical cancer research. It brings researchers together to share ideas and develop collaborations.

Join us to share ideas, develop collaborations and be inspired by the latest UK and international research. Play your part in helping to showcase the ground-breaking research at the UK's largest cancer research meeting. The NCRI Cancer Conference is the platform for cancer research in the UK, featuring research of international calibre. Submit your abstract today and gain recognition from your peers.

Important dates for your diary:

Abstract Submission: 4 April – 5 June
Earlybird registration: 4 April – 30 June
Standard registration: 1 July – 30 September
Later breaking abstract submission: 1 August – 22 August

http://conference.ncri.org.uk/

14–17 March 2017 Cell Death, Cell Stress and Metabolism Conference

Cancun, Mexico

The interplay between cell death, cell stress and metabolism plays a crucial role in shaping normal turnover of tissues, in sensing of danger posed by pathogens or other damage and the immunological response that is mounted to response to them.

At this conference we will discuss the basic biological principles that govern cell death, cell stress and metabolism. We will also cover how cellular stress and alterations in metabolism influence the cellular death programs such as apoptosis, necroptosis, ferroptosis and others.

Importantly, this conference aims to become the go-to forum at which the most current and up-to-date therapeutic avenues in the fields of cell death, cell stress and metabolism will be presented and discussed.

https://www.fusion-conferences.com/conference65.php

25–26 April 2017 Precision Medicine Congress

London, UK

Oxford Global Conferences are proud to present the Inaugural Precision Medicine Congress, taking place on the 25-26 April 2017 in London.
200 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies
Over 20 presentations and case studies focusing on the key developments in precision medicine discovery, diagnostics, clinical development and genomics.
2 interactive streams:
•    Precision Medicine and Diagnostics in discovery and development
•    Precision Medicine and Genomics

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities. This event is co-located with our Inaugural Advances in Companion Diagnostics Congress

http://www.precisionmedicine-congress.com/download-agenda/

25–26 April 2017 Advances in Companion Diagnostics Congress

London, UK

Oxford Global Conferences are proud to present the Inaugural Advances in Companion Diagnostics Congress, taking place on the 25-26 April 2017 in London.
200 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies
36 presentations and case studies focusing on the key developments in companion diagnostic development, molecular diagnostics, imaging, digital pathology and CDx for NGS technologies
4 interactive streams:
•    Companion Diagnostics (CDx) development
•    Advances in Molecular Diagnostics
•    Imaging and Diagnostic Development
•    Companion Diagnostics for Next-Generation Sequencing (NGS) platforms

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities. This event is co-located with the Inaugural Precision Medicine Congress

http://www.companiondiagnostics-congress.com/

15–16 May 2017 2nd Annual Advances in Immuno-Oncology Congress

London, UK

Oxford Global is proud to present its 2nd Annual Advances in Immuno-Oncology Congress, on the 15th & 16th of May 2017 in Central London. Over two days our event will bring together 200 senior level attendees from academia, research institutes and pharma companies to discuss the current challenges and future perspectives of Immuno-Oncology. This event provides an ideal platform to participate in formal 1-1 meetings and informal networking drinks with other key industry figures, as well as providing opportunities to exchange ideas with some of the most influential professionals in the field. Please download the agenda here: http://www.immunooncology-congress.com/download-agenda/

http://www.immunooncology-congress.com/

23–24 May 2017 Americas Antibody Congress 2017

Hilton San Diego Resort and Spa San Diego, CA

FRESH DATA. EXPERT SPEAKERS. DEEP CONTENT.

This May, researchers from pharma, academia, and biotech will descend on San Diego for two days of networking and content on the challenges to the antibody industry presented by the increased demand for antibody drugs to fight chronic illnesses.

With demand comes innovation. The only antibody event with new data and non-repetitive talks as a requirement to speak, Americas Antibody Congress 2017 will feature sessions on New Data in Antibody Discovery, New Data in Clinical and Commercial Development, and the therapeutic areas of Infectious Diseases and Oncology

https://goo.gl/9Yt1T4

23 May 2017 World Immunotherapy Congress USA 2017

Hilton San Diego Resort and Spa San Diego, CA

Discover. Develop. Get to market. For Biotech, Pharma, and Their Partners.

The demand for innovation in immunotherapy can only grow, and new breakthroughs are needed if success rates are to continue. That’s why World Immunotherapy Congress is coming to the USA after an acclaimed launch in Europe. This inaugural event will bring together the brightest and best minds in pharma, biotech, government and academia to build on the development and commercialization of new immunotherapy treatments.

Co-located with the Americas Antibody Congress, Immunotherapy World Congress USA features 2 days of in-depth case studies and discussions around Cell Therapy Strategies, Pre-Clinical Development and Innovative Therapeutic Approaches presented by our partners from biopharma and academia.

2017 Speakers include:

  • Alan Russell, Highmark Distinguished Career Professor, Carnegie Mellon University
  • Linda Bulone, Nurse Research Manager, Queens Hospital Cancer Center
  • Scott Marshall, Managing Director, Translational Informatics & Diagnostic Sciences, Precision for Medicine
  • Sushma Shivaswamy, Vice President, Research and Development, XBiotech

Register now: https://goo.gl/8ZgGhe

https://goo.gl/8ZgGhe

12–13 June 2017 18th Annual Drug Discovery Summit, 12-13 June 2017

Hotel Palace Berlin, Berlin, Germany

This congress brings together over 250 key opinion leaders and senior industry experts in drug discovery, to discuss the latest innovative discovery strategies in different therapeutic areas as well as the most effective enabling technologies and solutions.

Our event will have over 55 presentations and case studies and panel discussions focused on the key issues in drug discovery and medicinal chemistry.

Including 6 interactive streams

  • Drug Discovery Innovation and Strategies, Enabling Technologies
  • Novel Drug Target Discovery for Immuno-Therapy, Autoimmune Diseases and Oncology
  • Successful Phenotypic Drug Discovery: High Content Screening
  • RNAi Screening, Cancer Genomics and Gene Editing for Drug Discovery
  • Discovery Chemistry, Medicinal and Computational Chemistry
  • Medicinal Chemistry and Drug Design: Novel Approaches.

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities.

Co-located with our 5th Annual Discovery Chemistry and Drug Design Congress and our inaugural Microbiome Discovery and Development Congress

Free Webinars available:

Drug Discovery Open Innovation & Outsourcing
Hosted by Patrick Kleyn, Director of Drug Target Innovation, EMD Serono
Register for Free Today: http://bit.ly/2f046Yl

Phenotypic Screening in Drug Discovery- Novel Tools & Applications
Hosted by Paul Andrews, Director of Operations, National Phenotypic Screening Centre (NPSC), School of Life Sciences, University of Dundee
Register for Free Today: http://bit.ly/2f44Xpd

Disruptive Technologies & Artificial Intelligence in Drug Discovery
Hosted by Chris Gibson, CEO, Recursion Pharmaceuticals
Register for Free Today: http://bit.ly/2f4a34F

You can also follow us on Twitter @drugdiscovery1 and join the congress conversation on #DDSummit17

For further information on the congress and the webinars, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call +44 (0) 1865 248 455.

http://www.drugdiscovery-summit1.com/

10–11 July 2017 Digital Pathology Congress: USA

Palmer House Hilton Hotel, Chicago, IL, USA

As experts position themselves for FDA-approval of primary diagnosis,
the congress will examine the applications and benefits of adopting
digital pathology as well as the business case to be made for it. With
over 200 industry and academic experts expected over the two days, the
congress will provide the opportunity to take home cutting edge
strategies, analysis techniques, case study examples and methods to
allow you to fully understand both the technology and accompanying
informatics and image analysis tools and utilize digital pathology to
its greatest potential.

http://www.global-engage.com/event/digital-pathology-usa

9–10 October 2017 4th Annual Drug Discovery USA Congress

San Diego, USA

Oxford Global’s 4th Annual Drug Discovery USA Congress will take place on 9 – 10 October 2017 in San Diego, USA, bringing together over 250 key opinion leaders in drug discovery. This exciting conference showcases the latest technologies and approaches being utilised across Immuno-therapy, Autoimmune diseases, Neuroscience and Oncology. Further sessions consider the key updates in medicinal and computational chemistry. The two-day congress offers an interactive platform for high level discussions, ensuring valuable networking and interactive sessions.
View Agenda: http://bit.ly/1Li0Wd4
4 Interactive Streams:
• Drug Discovery Innovation and Strategies, Enabling Technologies for Immuno-therapy, Autoimmune Diseases, Neuroscience & Oncology
• Successful Phenotypic Drug Discovery: High Content Screening
• Discovery Chemistry: Medicinal and Computational Chemistry
• Discovery Chemistry: Medicinal Chemistry and Novel Approaches to Drug Design

http://bit.ly/1Li0Wd4

18–21 October 2017 9th World Congress of Melanoma and the 14th International Congress of the Society for Melanoma Research

Brisbane, Australia

The 9th World Congress of Melanoma and the 14th International Congress of the Society for Melanoma Research will be held from 18th to 21st October 2017 in Brisbane, Australia. The joint meeting will bring together the world’s leading melanoma researchers and clinicians to showcase the latest developments in melanoma diagnosis, treatment and research.

This global summit will accelerate scientific and clinical investigations into melanoma, providing an opportunity for delegates from multi-disciplinary fields to meet in a warm climate to exchange knowledge and expertise.

We plan to inspire new partnerships and innovations, and will offer a range of significant benefits to international delegates from across the world, including opportunities to explore new professional horizons that pivot from a uniquely global focus on melanoma and skin cancer control.

http://worldmelanoma2017.com/

26–28 October 2017 3rd World Congress on Controversies in Breast Cancer (CoBrCa)

Tokyo, Japan

The 3rd World Congress on Controversies in Breast Cancer (CoBrCa) will take place October 26-28, 2017 in Tokyo, Japan. It will directly address controversial issues in breast cancer faced by clinicians in their daily practice. The congress will focus on key issues in medical oncology, surgery, radiation oncology, reconstruction and pathology. The congress will also provide a forum to effectively debate these unresolved clinical and therapeutic problems.

http://cobrca.org/

Back to Top